about
In Vitro Cell Models for Ophthalmic Drug Development ApplicationsControlled ocular drug delivery with nanomicellesSystemic side effects of eye drops: a pharmacokinetic perspectiveHuman corneal cell culture models for drug toxicity studiesEfflux protein expression in human stem cell-derived retinal pigment epithelial cellsExtended latanoprost release from commercial contact lenses: in vitro studies using corneal modelssFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In VivoPhloroglucinol protects retinal pigment epithelium and photoreceptor against all-trans-retinal-induced toxicity and inhibits A2E formationBioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue.HIV-1 Tat protein alter the tight junction integrity and function of retinal pigment epithelium: an in vitro study.Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells.Gap junctions and blood-tissue barriersSolid lipid nanoparticles for ocular drug delivery.Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interfaceNovel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells.Doxycycline loaded poly(ethylene glycol) hydrogels for healing vesicant-induced ocular wounds.Cellular models and therapies for age-related macular degeneration.Development of immortalized rat conjunctival epithelial cell lines: an in vitro model to examine transepithelial antigen delivery.mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs.Functional and molecular aspects of biotin uptake via SMVT in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells.Chitosan nanoparticles for drug delivery to the eye.A current practice for predicting ocular toxicity of systemically delivered drugs.The role of blood-ocular barrier transporters in retinal drug disposition: an overview.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.In vitro cell culture models to study the corneal drug absorption.Polymeric vectors for ocular gene delivery.Cell-based in vitro models for predicting drug permeability.Ocular Drug Delivery; Impact of in vitro Cell Culture Models.Novel strategies for anterior segment ocular drug delivery.Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.Ocular toxicity assessment from systemically administered xenobiotics: considerations in drug development.Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye.Pharmacokinetics of intravitreal antibiotics in endophthalmitis.Xeno-Free and Defined Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Functionally Integrate in a Large-Eyed Preclinical Model.Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin.Advances in the use of prodrugs for drug delivery to the eye.Minimally invasive microneedles for ocular drug delivery.Vitrigel-eye irritancy test method using HCE-T cells.
P2860
Q26751148-05602FEB-1F74-49A0-A8FC-729BF21DC13AQ27012087-861B82D6-377E-4605-AB2B-78250A05042EQ28066720-9B38A589-4E2E-4783-8FBD-251CCF7CD6AAQ28080232-F041A1D4-2E44-4F78-BE47-862DB536A2E0Q28478917-CEAD20AE-99B9-47C0-AFF7-776134BB4F55Q28542904-156B0324-BD98-41B0-9D4A-F1A6ABA68DFDQ28552652-FF0692CF-DA77-4422-873C-14B46DDD4B43Q28830034-FB3ADF63-50C6-462F-8D3D-D98D2A9EC50FQ33321483-B2D198AF-CB46-43D3-9872-EBD760D8DFD2Q33341177-B0BAB8F4-593D-4951-B347-B85A6591510CQ33849404-0943B7A7-05CE-44BB-B466-0B9BB02CE6F5Q33941978-B8903610-5917-4898-B014-FA333AB3C5E9Q34116807-515E8F9F-9D98-4A32-8EE3-04F22387AFF6Q34364138-FD3B2C5B-3433-4848-86F7-68E81E06E9AEQ34512297-57E12315-37F4-47FB-A224-2A5FC830D782Q34604767-0AE18256-1ACB-4482-9547-1582955E8AA7Q35200979-24FA0F09-0AF9-48D2-8006-FF0934C8762CQ35558042-B954F723-C515-4A1B-AAF7-4B08D52FE910Q35729154-E54F7E76-7F9E-430E-BE0D-D73774F58D32Q35990861-EBE5AEFC-E9B1-4AD7-A04D-DB6F8BF7092EQ36331516-39714759-B693-434B-A5CC-57E335184FE5Q37416144-D3A3EBBC-F716-4256-8528-A2BFC7C379ACQ37514300-CB71BD3B-78A2-491A-93DE-BF6CA1E057C9Q37741227-95E23001-D1FE-4555-A6A1-413736F25FA1Q37769529-3A69A013-1017-469A-8EB0-5FD7B2B98A58Q37850457-AC00FB5B-572E-484F-8D60-028D09478A7FQ37920729-9FACE565-21AC-4B3C-BD6C-F897CA7F34E6Q37994260-9229C200-372B-4F5C-9461-60B83C3D1129Q38063860-10495897-ECB4-4995-8F39-8681FA8187DCQ38065184-2738CF7B-7735-4112-86ED-9F509DDE12B0Q38092131-10CDA7B9-89AD-4F08-956F-41D691C9FFA4Q38101516-0AC0BCC8-AB83-4764-BDFA-2D3DD538F9D8Q38149325-949F857D-1B39-4227-B713-D80FBAC2CBC4Q38196445-99A7F55A-09C4-4201-823E-DFB8A2DB0FD8Q38350572-2DBC7CCE-65D2-43A2-A1D1-853F52556C58Q38807010-AA36B29C-3066-40D0-BABC-30C3882365C6Q38901841-66FC64A9-2532-4BDA-96B0-B2D7B06685C0Q38904119-9C9875C4-C5DE-4C21-A519-0482D5606B39Q38916649-D7193126-2E72-42BD-B6A0-C77C8FC769DBQ39122750-C1F2FD8A-66CB-4396-8E33-06FFF10C8D49
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cell culture models of the ocular barriers.
@ast
Cell culture models of the ocular barriers.
@en
type
label
Cell culture models of the ocular barriers.
@ast
Cell culture models of the ocular barriers.
@en
prefLabel
Cell culture models of the ocular barriers.
@ast
Cell culture models of the ocular barriers.
@en
P2093
P1476
Cell culture models of the ocular barriers.
@en
P2093
Arto Urtti
Elisa Toropainen
Margit Hornof
P304
P356
10.1016/J.EJPB.2005.01.009
P407
P577
2005-07-01T00:00:00Z